Researchers publish review on African turquoise killifish as a compressed model of vertebrate aging

A peer-reviewed publication outlines the role of the short-lived African turquoise killifish as a compressed vertebrate model of aging, establishing its potential for rapid, single-generation screening of therapeutic interventions.

Researchers from Swansea University Medical School published a review in Essays in Biochemistry analyzing the African turquoise killifish (Nothobranchius furzeri) as a compressed vertebrate model for longevity and age-related disease research.

The authors reported that the killifish completes its life cycle in a few months, making it the shortest-lived vertebrate breedable in captivity, showing progressive, systemic decline rather than abrupt early death.

Over the past decade, the development of a sequenced genome, CRISPR/Cas9 engineering, standardized husbandry, and multi-omic atlases have established the killifish as a systems-level aging platform.

The publication reviewed how the killifish reproduces molecular hallmarks of aging, including genomic instability, telomere attrition, epigenetic changes, mitochondrial dysfunction, and cellular senescence, while noting that the depth of evidence differs between hallmarks.

Evaluating longevity interventions in standard mammalian models like mice is highly time-consuming, requiring several years to gather complete survival data.

The killifish compresses vertebrate aging into a multi-month timeframe, allowing researchers to study physiological aging, organ-level pathologies, and candidate interventions within a single generation.

The combination of a compressed life cycle and established CRISPR/Cas9 genetic tractability provides an expedited route for executing functional genomic screens in a vertebrate system.

Adoption of the African turquoise killifish platform could lower preclinical development timelines and associated discovery costs for biotech firms.

Therapeutic developers targeting cell-intrinsic mechanisms such as cellular senescence or mitochondrial dysfunction could utilize this high-throughput vertebrate model to filter candidates before entering rodent or primate trials.

A standardized, rapid vertebrate model could help establish early-stage efficacy data, potentially improving the translatability of preclinical pipelines.

Further research to resolve existing literature conflicts in the killifish model, specifically regarding telomere attrition dynamics, the nature of diapause, and the direction of age-related epigenetic changes.